This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Human immunodeficiency virus [HIV] disease resulting in other specified diseases
AB1_OTHER_DISEASE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
19 |
4. Check minimum number of eventsNone |
19 |
5. Include endpointsNone |
19 |
6. Filter based on genotype QC (FinnGen only) |
19 |
Control definitions (FinnGen only)
- Control exclude
- AB1_HIV
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Human immunodeficiency virus [HIV] disease resulting in other specified diseases
based on the number of shared cases.
Similar with more cases:
- Human immunodeficiency virus [HIV] disease
- Certain infectious and parasitic diseases
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 165 | 53 | 107 |
| Only index persons | 125 | 43 | 82 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 45.77 | 46.32 | 45.82 |
| Only index persons | 46.04 | 44.51 | 46.84 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 19 | 6 | 13 |
| Unadjusted period prevalence (%) | 0.00 | 0.00 | 0.01 |
| Median age at first event (years) | 49.76 | 47.20 | 50.94 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3017143) Hepatitis C virus Ab [Presence] in Serum
12
22
12.81
5.92
4.3
1.5
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
5
0
+∞
5.44
4.8
0.0
g/mol
24.4
—
—
5
0
(3019832) Treponema pallidum Ab [Presence] in Serum
9
11
14.24
5.28
2.2
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
13
39
8.28
4.50
17.5
5.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
7
9
11.44
3.95
5.4
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
11
38
5.44
3.14
1.7
1.7
mmol/l
1.5
1.4
0.23
11
28
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
13
54
5.41
2.94
4.2
3.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
11
42
4.80
2.80
4.5
3.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
7
9.14
2.72
2.4
1.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
7
17
5.85
2.66
1.6
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
8
7.97
2.53
3.0
1.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
7
21
4.64
2.22
1.1
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
5
11
5.73
2.08
1.4
2.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
8
33
3.43
1.80
5.5
3.7
—
—
—
0
0
(3015736) pH of Urine
11
53
3.53
1.80
5.1
3.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
9
40
3.35
1.71
21.3
8.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
11
57
3.19
1.71
3.6
8.4
mmol/l
1.2
1.2
0.03
11
49
(3021589) Normoblasts [#/volume] in Blood
12
66
3.20
1.64
24.8
11.4
e9/l
0.0
0.0
0.00
12
55
(3012544) pH of Venous blood
5
15
4.12
1.63
2.0
5.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
7
29
3.21
1.58
5.1
2.8
ng/l
11.3
184.5
—
7
21
(3042936) Bacteria identified in Isolate by Culture
6
24
3.17
1.43
1.5
1.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
11
61
2.89
1.40
18.1
9.2
inr
1.3
1.3
—
5
21
(3013650) Neutrophils [#/volume] in Blood by Automated count
13
84
2.72
1.27
24.1
14.9
e9/l
2.8
4.5
3.22
13
76
(3037467) Urinalysis macro (dipstick) panel - Urine
14
95
2.79
1.25
9.2
4.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
7
35
2.57
1.15
1.9
1.6
mg/l
2.5
1.0
—
7
30
(40768804) Tissue Pathology biopsy report
8
44
2.40
1.03
3.3
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
6
30
2.45
0.97
1.0
1.7
nmol/l
15.5
24.1
—
6
25
(3023368) Bacteria identified in Blood by Culture
7
42
2.05
0.79
4.3
5.7
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
5
25
2.34
0.79
1.6
2.0
s
30.2
29.0
—
5
25
(3009508) Creatinine [Moles/volume] in Urine
8
52
1.92
0.72
5.3
2.7
mmol/l
10.1
9.3
—
8
46
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
5
28
2.06
0.72
2.0
2.0
pmol/l
519.6
522.5
—
5
28
(3014576) Chloride [Moles/volume] in Serum or Plasma
0
20
0.00
0.64
0.0
4.2
—
104.6
—
0
20
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
0
20
0.00
0.64
0.0
4.2
—
26.9
—
0
9
(3013707) Erythrocyte sedimentation rate by Westergren method
14
117
1.74
0.48
6.4
3.6
mm/h
12.1
11.7
0.05
14
107
(3026008) Bacteria identified in Urine by Culture
5
35
1.58
0.43
2.6
2.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
17
0.00
0.43
0.0
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
18
0.00
0.42
0.0
2.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
7
54
1.47
0.36
4.3
1.9
u/l
97.4
129.2
—
7
48
(3044889) 12 lead EKG panel
14
118
1.70
0.34
3.7
3.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
5
36
1.52
0.27
2.2
3.9
ng/l
1696.2
2323.3
—
5
30
(3019225) pH of Specimen
0
11
0.00
0.22
0.0
10.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
0
11
0.00
0.22
0.0
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
0
11
0.00
0.22
0.0
4.1
—
4.8
—
0
11
(3022621) pH of Urine by Test strip
0
11
0.00
0.22
0.0
1.4
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
0
11
0.00
0.22
0.0
3.8
—
94.9
—
0
11
(4010399)
0
11
0.00
0.22
0.0
1.4
—
—
—
0
0
(3020891) Body temperature
0
11
0.00
0.22
0.0
4.0
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
0
10
0.00
0.22
0.0
3.6
—
0.7
—
0
10
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
0
10
0.00
0.22
0.0
3.6
—
1.4
—
0
10
(3039443) Prostate specific Ag panel - Serum or Plasma
0
12
0.00
0.22
0.0
1.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
5
46
1.12
0.10
5.4
3.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
5
60
0.77
0.10
5.6
5.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
10
106
0.88
0.09
3.1
2.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
0
7
0.00
0.00
0.0
2.7
—
4.1
—
0
7
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
0
8
0.00
0.00
0.0
3.1
—
1.2
—
0
8
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
218.1
—
0
5
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
0
9
0.00
0.00
0.0
3.6
—
2.1
—
0
9
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
0
8
0.00
0.00
0.0
4.0
—
47.2
—
0
8
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
0
9
0.00
0.00
0.0
4.6
—
24.5
—
0
9
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
520.2
—
0
5
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
6
63
0.93
0.00
5.8
3.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
0
8
0.00
0.00
0.0
5.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_OTHER_DISEASE and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have AB1_OTHER_DISEASE.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: AB1_OTHER_DISEASE – Human immunodeficiency virus [HIV] disease resulting in other specified diseases
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data